Gabergic compounds and schizophrenia.
D001418:Baclofen / Q000627:therapeutic use; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D014635:Valproic Acid / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D001418:Baclofen